A Study of LY2940680 in Small Cell Lung Cancer

Clinical trial NCT01722292 · TERMINATED

Trial details

NCT number: NCT01722292
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Carcinoma

Start date: 2013-01-01
Primary completion: 2015-02-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.